BODYQ PTE. LTD.

BodyQ shares a mission to measure and map inflammatory driven health problems at their earliest onset - in the space between our cells. In partnership with Body Digital, BodyQ is driving the regulation of cellular-level inflammation mapping towards global clinical use. The application suite under development leverage

Operating in medtech, digital health, ai based in Singapore, BODYQ PTE. LTD. was founded in 2024.

Profile

BodyQ shares a mission to measure and map inflammatory driven health problems at their earliest onset - in the space between our cells.

In partnership with Body Digital, BodyQ is driving the regulation of cellular-level inflammation mapping towards global clinical use.

The application suite under development leverages advances in quantitative magnetic resonance imaging to give a new 100x magnification:

1) LiverMap: for screening and monitoring inflammatory-driven liver conditions that commence with scarring at cellular level.

2) BrainMap: mapping changes in brain health with age and inflammation to quantify the early signs of dementia with neuron damage.

Together we aim to shed light on inflammatory driven diseases before they become chronic, adding healthy life back onto our years.

Its activity falls under medtech, digital health, ai; the profile below is assembled from public directory data.

Singapore is where the company is located.

Directory data places it at the Startup SG directory startup stage.

Its team size is recorded as 1 - 10 employees.

Website: body.digital